Compare BALY & TLRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BALY | TLRY |
|---|---|---|
| Founded | 2004 | N/A |
| Country | United States | Canada |
| Employees | 11700 | N/A |
| Industry | Hotels/Resorts | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 731.8M | 688.9M |
| IPO Year | 2019 | 2018 |
| Metric | BALY | TLRY |
|---|---|---|
| Price | $13.80 | $4.74 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 4 |
| Target Price | $12.40 | ★ $72.33 |
| AVG Volume (30 Days) | 43.2K | ★ 3.3M |
| Earning Date | 05-11-2026 | 04-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 8.37 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,436,189,000.00 | N/A |
| Revenue This Year | $21.50 | $8.79 |
| Revenue Next Year | $5.45 | $19.98 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $8.79 | $0.39 |
| 52 Week High | $20.74 | $15.70 |
| Indicator | BALY | TLRY |
|---|---|---|
| Relative Strength Index (RSI) | 52.48 | 33.48 |
| Support Level | $12.10 | $1.12 |
| Resistance Level | $14.39 | $5.71 |
| Average True Range (ATR) | 0.91 | 0.27 |
| MACD | -0.10 | -0.01 |
| Stochastic Oscillator | 45.40 | 12.16 |
Ballys Corp is a gaming, hospitality, entertainment, and technology company operating across casino, interactive, and lottery markets. It provides physical and interactive gaming experiences, including casino gaming, iGaming, sportsbook, online bingo, free-to-play games, and technology-driven lottery solutions. The company's segments include Casinos & Resorts, which generates maximum revenue and operates casino and resort properties, a horse racetrack, and a golf course; Bally's Intralot B2B, which provides lottery and technology services; Bally's Intralot B2C, which includes interactive gaming and lottery operations, including a UK casino; and North America Interactive, which includes sports betting and iGaming operations in the United States and Canada.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.